tiprankstipranks
Trending News
More News >
Laekna, Inc. (HK:2105)
:2105
Hong Kong Market

Laekna, Inc. (2105) Stock Forecast & Price Target

Compare
4 Followers
See the Price Targets and Ratings of:

2105 Financial Forecast

2105 Earnings Forecast

The previous quarter’s earnings for 2105 were -HK$0.38.
The previous quarter’s earnings for 2105 were -HK$0.38.
No data currently available

2105 Sales Forecast

The previous quarter’s earnings for 2105 were HK$0.00.
The previous quarter’s earnings for 2105 were HK$0.00.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
DBS
HK$26.45HK$24.16
Buy
63.24%
Upside
Reiterated
09/29/25
Laekna, Inc. (2105) Gets a Buy from DBSLower TP by 9% to reflect share dilution post fundraising; Re-iterate Buy as we see a higher likelihood that Eli Lilly (LLY US) will license in Laekna’s LAE102 for muscle loss prevention
Guotai Haitong Analyst forecast on HK:2105
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
HK$29.19
Buy
97.23%
Upside
Reiterated
08/13/25
KeyBanc Analyst forecast on HK:2105
Unknown Analyst
KeyBanc
Not Ranked
KeyBanc
HK$31.24
Buy
111.08%
Upside
Reiterated
06/28/25
China Securities International Analyst forecast on HK:2105
Unknown Analyst
China Securities International
Not Ranked
China Securities International
HK$41.3
Buy
179.05%
Upside
Reiterated
06/26/25
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
DBS
HK$26.45HK$24.16
Buy
63.24%
Upside
Reiterated
09/29/25
Laekna, Inc. (2105) Gets a Buy from DBSLower TP by 9% to reflect share dilution post fundraising; Re-iterate Buy as we see a higher likelihood that Eli Lilly (LLY US) will license in Laekna’s LAE102 for muscle loss prevention
Guotai Haitong Analyst forecast on HK:2105
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
HK$29.19
Buy
97.23%
Upside
Reiterated
08/13/25
KeyBanc Analyst forecast on HK:2105
Unknown Analyst
KeyBanc
Not Ranked
KeyBanc
HK$31.24
Buy
111.08%
Upside
Reiterated
06/28/25
China Securities International Analyst forecast on HK:2105
Unknown Analyst
China Securities International
Not Ranked
China Securities International
HK$41.3
Buy
179.05%
Upside
Reiterated
06/26/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Laekna, Inc.

3 Months
xxx
Success Rate
1/4 ratings generated profit
25%
Average Return
-15.53%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 25.00% of your transactions generating a profit, with an average return of -15.53% per trade.
1 Year
Success Rate
0/4 ratings generated profit
0%
Average Return
-21.65%
reiterated a buy rating 4 months ago
Copying Mark Kong CFA's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -21.65% per trade.
2 Years
xxx
Success Rate
0/4 ratings generated profit
0%
Average Return
-21.65%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -21.65% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

2105 Analyst Recommendation Trends

Rating
May 25
Jun 25
Jul 25
Aug 25
Sep 25
Strong Buy
2
3
3
2
1
Buy
0
2
2
4
3
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
2
5
5
6
4
In the current month, 2105 has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 2105 average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

2105 Stock Forecast FAQ

What is HK:2105’s average 12-month price target, according to analysts?
Currently, no data Available
What is HK:2105’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HK:2105, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Laekna, Inc. a Buy, Sell or Hold?
      Laekna, Inc. has a consensus rating of Moderate Buy, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
        What is Laekna, Inc.’s share price target?
        Currently, no data Available
        What do analysts say about Laekna, Inc.?
        Laekna, Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
          How can I buy shares of Laekna, Inc.?
          To buy shares of HK:2105, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.